Related Experiment Video
Updated: Mar 17, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity
Ariella Glasner1, Ziv Roth2, Alexander Varvak3
1The Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, The Institute of Medical Research Israel Canada (IMRIC) , Jerusalem, Israel.
Abstract:
Natural killer (NK) cells kill tumor and virus-infected cells using activating NK cell receptors. One of the major NK-activating receptors is NKp46 and its mouse ortholog Ncr1. NKp46/Ncr1 is expressed exclusively on NK cells and on a subset of innate lymphoid cells. NKp46/Ncr1 was shown to be involved in a myriad of pathologies and immunological settings. Specifically, NKp46/Ncr1 was shown to interact with the viral hemagglutinin (HA) protein and with an unknown tumor/cellular ligand. NKp46 and Ncr1 are structurally similar; however, they are substantially different in their glycosylation patterns. Although the human NKp46 carries both O- and N-glycosylations that are essential for its activity, the mouse Ncr1 was predicted to have N-linked glycosylations only. Here we discovered using prediction algorithms and high-performance liquid chromatography analysis that Ncr1 carries two putative novel O-glycosylations, one of which (Thr 225) is conserved in NKp46. We next used surface plasmon resonance, biochemical, mutational and functional in vitro and in vivo assays to demonstrate that the putative O-glycosylations of Ncr1 are critical for its function.
Insights
Mouse Ncr1, a key natural killer cell receptor, possesses novel O-glycosylations essential for its function. These findings reveal new insights into NK cell receptor activity and regulation.
Area of Science:
- Immunology
- Cell Biology
- Glycobiology
Background:
- Natural killer (NK) cells are crucial for innate immunity, eliminating tumor and virus-infected cells via activating receptors.
- NKp46 (human) and its mouse ortholog, Ncr1, are key activating NK cell receptors involved in various pathologies.
- While human NKp46 requires O- and N-glycosylations for activity, mouse Ncr1 was predicted to have only N-linked glycosylations.
Purpose of the Study:
- To investigate the glycosylation patterns of mouse Ncr1.
- To determine the functional significance of Ncr1 glycosylations in NK cell activity.
Main Methods:
- Computational prediction algorithms and high-performance liquid chromatography (HPLC) for glycosylation analysis.
- Surface plasmon resonance (SPR), biochemical assays, mutational analysis.
- In vitro and in vivo functional assays to assess Ncr1 activity.
Main Results:
- Discovery of two novel putative O-glycosylations on mouse Ncr1, with one conserved in human NKp46 (Thr 225).
- Demonstration that these O-glycosylations are critical for Ncr1 function.
- Evidence that Ncr1 glycosylation differs significantly from initial predictions.
Conclusions:
- Mouse Ncr1 possesses previously unrecognized O-glycosylations essential for its role in NK cell-mediated immunity.
- These findings highlight the importance of glycosylation in regulating NK cell receptor function and provide a basis for further research into NK cell activation mechanisms.
More Related Videos
Related Concept Videos
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Glycosylation
Glycosylation occurs in...

